This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Robert D. Reinecke, MD

Arch Ophthalmol. 1970;84(3):259.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

OVERT temporal arteritis, a documented cause of blindness since 1932,¹ has also been recognized to exist in an occult form since 1962.² Since then, the generalized nature of the disease has been gradually documented and the term "giant cell arteritis" found more appropriate. Some studies have suggested more than a 10% mortality associated with the disease.³ Cortisone-like drugs were found to relieve dramatically the acute symptoms of the disease and to prevent blindness in many patients.⁴ The efficiency of cortisone in the disease has caused speculation that the lives of some patients could be prolonged if they were carefully treated.

In 1957, Barber⁵ found "polymyalgia rheumatica" a useful term to describe a syndrome previously known as "senile rheumatic gout," "humeroscapular periarthrosis," "periextra-articular rheumatism," and "anarthritic rheumatoid disease." Biopsies subsequently showed that some polymyalgia rheumatica patients actually had giant cell arteritis.⁶ Still later some of . . . [Full Text PDF of this Article]

Author Affiliations
Albany NY

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?